Search Results - "Bès, Cédric"

Refine Results
  1. 1

    Physicochemical and Biological Characterization of RTXM83, a New Rituximab Biosimilar by Cerutti, María L., Pesce, Analía, Bès, Cédric, Seigelchifer, Mauricio

    “…Background RTXM83 is a rituximab biosimilar with proven clinical safety and efficacy. It is the first rituximab biosimilar developed and approved in South…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases by Chardès, Thierry, Chapal, Nicolas, Bresson, Damien, Bès, Cédric, Giudicelli, Véronique, Lefranc, Marie-Paule, Péraldi-Roux, Sylvie

    Published in Immunogenetics (New York) (01-06-2002)
    “…Human anti-thyroid peroxidase (TPO) autoantibodies (aAb) are generated during autoimmune thyroid diseases (AITD). Within recent years, increasing knowledge of…”
    Get full text
    Journal Article
  6. 6

    Application of the Spot method to the identification of peptides and amino acids from the antibody paratope that contribute to antigen binding by Laune, Daniel, Molina, Franck, Ferrières, Gaëlle, Villard, Sylvie, Bès, Cédric, Rieunier, François, Chardès, Thierry, Granier, Claude

    Published in Journal of immunological methods (01-09-2002)
    “…Overlapping peptide scans prepared by Spot synthesis have been used to map interaction sites in several systems. Here we report our experience with this…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR‐H1‐derived peptide CB1 1 by Bès, Cédric, Briant-Longuet, Laurence, Cerruti, Martine, DeBerardinis, Piergiuseppe, Devauchelle, Gérard, Devaux, Christian, Granier, Claude, Chardès, Thierry

    Published in FEBS letters (09-11-2001)
    “…A systematic exploration of the V H 2/V κ 12–13 variable domains of the anti‐CD4 monoclonal antibody (mAb) 13B8.2 was performed by the Spot method to screen…”
    Get full text
    Journal Article
  17. 17

    Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR‐H1‐derived peptide CB11 by Bès, Cédric, Briant-Longuet, Laurence, Cerruti, Martine, DeBerardinis, Piergiuseppe, Devauchelle, Gérard, Devaux, Christian, Granier, Claude, Chardès, Thierry

    Published in FEBS letters (09-11-2001)
    “…A systematic exploration of the VH2/Vκ12–13 variable domains of the anti‐CD4 monoclonal antibody (mAb) 13B8.2 was performed by the Spot method to screen for…”
    Get full text
    Journal Article
  18. 18

    The human anti-thyroid peroxidase autoantibody repertoire in Graves'and Hashimoto's autoimmune thyroid disease by Chardès, Thierry, Chapal, Nicolas, Bresson, Damien, Bès, Cédric, Giudicelli, Véronique, Lefranc, Marie-Paule, Peraldi-Roux, Sylvie

    Published in Immunogenetics (New York) (01-06-2002)
    “…Human anti-thyroid peroxidase (TPO) autoantibodies (aAb) are generated during autoimmune thyroid diseases (AITD). Within recent years, increasing knowledge of…”
    Get full text
    Journal Article
  19. 19

    Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1 by Bès, Cédric, Briant-Longuet, Laurence, Cerruti, Martine, DeBerardinis, Piergiuseppe, Devauchelle, Gérard, Devaux, Christian, Granier, Claude, Chardès, Thierry

    Published in FEBS letters (09-11-2001)
    “…A systematic exploration of the V H2/V κ12–13 variable domains of the anti-CD4 monoclonal antibody (mAb) 13B8.2 was performed by the Spot method to screen for…”
    Get full text
    Journal Article
  20. 20

    The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation by Bès, C, Cerutti, M, Briant-Longuet, L, Bresson, D, Peraldi-Roux, S, Pugnière, M, Mani, J C, Pau, B, Devaux, C, Granier, C, Devauchelle, G, Chardès, T

    Published in Human antibodies (2001)
    “…The anti-CD4 mAb 13B8.2, directed against the CDR3-like loop of the D1 domain of CD4, inhibits signal transduction pathways leading to both T cell activation…”
    Get more information
    Journal Article